1993
DOI: 10.1084/jem.178.5.1607
|View full text |Cite
|
Sign up to set email alerts
|

Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.

Abstract: We have previously produced lines of rats transgenic for HLA-B27 and human beta 2-microglobulin (h beta 2m) that develop a progressive inflammatory disease sharing many clinical and histologic features with the B27-associated human spondyloarthropathies, including gut and male genital inflammation, arthritis, and psoriasiform skin lesions. Other transgenic lines that express lower levels of B27 and h beta 2m remain healthy. To investigate the cellular basis for the multisystem inflammatory disease in these rat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
94
1
1

Year Published

1995
1995
2010
2010

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 160 publications
(99 citation statements)
references
References 37 publications
3
94
1
1
Order By: Relevance
“…In our B27 transgenic mouse model as well as in transgenic mouse models described by other investigators (26,(52)(53)(54)(55)(56), but unlike the findings in the B27 transgenic rat model (4)(5)(6), the transgenic mouse model studied by Weinreich et a1 (57), or the recently described model of HLA-B27 transgenic mice lacking P2m (58), no spontaneous or induced manifestation of disease occurs. It nevertheless provides a model suitable for defining a bacteria-specific CD8 immune response.…”
Section: Discussioncontrasting
confidence: 45%
See 1 more Smart Citation
“…In our B27 transgenic mouse model as well as in transgenic mouse models described by other investigators (26,(52)(53)(54)(55)(56), but unlike the findings in the B27 transgenic rat model (4)(5)(6), the transgenic mouse model studied by Weinreich et a1 (57), or the recently described model of HLA-B27 transgenic mice lacking P2m (58), no spontaneous or induced manifestation of disease occurs. It nevertheless provides a model suitable for defining a bacteria-specific CD8 immune response.…”
Section: Discussioncontrasting
confidence: 45%
“…The basis for this association is unclear (2,3). Transgenic rats expressing HLA-B*2705 and human P,-microglobulin @,m) develop a disease that shares clinical and histologic features with B27-associated human spondylarthropathies; hence, it is assumed that HLA-B*2705 is itself involved in the pathogenesis of these diseases (4)(5)(6). In ReA, the presence of persistent bacterial antigen in the joints suggests that bacterial-derived peptides might be presented to CD8-positive T cells by HLA-B27 (7).…”
mentioning
confidence: 99%
“…In rats, expression of HLA-B27 outside the bone marrow compartment is not necessary for spontaneous development of inflammatory disease (30), and it remains unclear precisely what cell type (or types) are critical in humans. These studies raise the possibility that there are cell-specific differences in the effects of HLA-B27 and underscore the potential importance of macrophages and up-regulation of HLA class I expression.…”
Section: Discussionmentioning
confidence: 99%
“…We used mouse mAb HC10 (IgG2a specific for HLA-B free heavy chains), B9.12.1 (IgG2a specific for folded HLA-A, -B, and -C), B1.23.2 (IgG2a specific for folded HLA-B and -C), BBM.1 (IgG2b specific for Hu␤ 2 m), and OX18 (IgG1 specific for rat MHC class I). Their references, production, and use have been previously described (9,22,28).…”
Section: Methodsmentioning
confidence: 99%